 Matthew Frank
Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 25 | 2023 | 202 | 5.770 |
Why?
| | Hippocampus | 29 | 2020 | 697 | 3.490 |
Why?
| | HMGB1 Protein | 8 | 2019 | 48 | 2.670 |
Why?
| | Glucocorticoids | 14 | 2019 | 535 | 2.640 |
Why?
| | Stress, Psychological | 14 | 2019 | 946 | 2.500 |
Why?
| | Inflammasomes | 7 | 2023 | 115 | 2.450 |
Why?
| | Inflammation | 22 | 2023 | 2485 | 2.030 |
Why?
| | Lipopolysaccharides | 18 | 2023 | 817 | 1.970 |
Why?
| | Inflammation Mediators | 7 | 2018 | 476 | 1.890 |
Why?
| | Rats | 45 | 2023 | 4973 | 1.670 |
Why?
| | Rats, Sprague-Dawley | 33 | 2022 | 2212 | 1.650 |
Why?
| | Encephalitis | 6 | 2018 | 127 | 1.450 |
Why?
| | Brain | 9 | 2019 | 2380 | 1.440 |
Why?
| | Stress, Physiological | 4 | 2017 | 377 | 1.400 |
Why?
| | Receptors, Immunologic | 3 | 2019 | 201 | 1.210 |
Why?
| | Alarmins | 4 | 2018 | 26 | 1.190 |
Why?
| | Mycobacterium | 4 | 2023 | 103 | 1.040 |
Why?
| | Anti-Inflammatory Agents | 3 | 2023 | 451 | 1.010 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 9 | 2023 | 144 | 0.900 |
Why?
| | Aging | 10 | 2018 | 1624 | 0.850 |
Why?
| | Animals | 54 | 2023 | 31867 | 0.840 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 4 | 2012 | 254 | 0.800 |
Why?
| | Interleukin-1beta | 11 | 2023 | 370 | 0.740 |
Why?
| | Cytokines | 12 | 2018 | 1843 | 0.680 |
Why?
| | Limbic System | 1 | 2019 | 43 | 0.650 |
Why?
| | Cisterna Magna | 4 | 2013 | 8 | 0.640 |
Why?
| | Probiotics | 1 | 2018 | 46 | 0.600 |
Why?
| | Escherichia coli Infections | 4 | 2014 | 100 | 0.600 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 386 | 0.590 |
Why?
| | Mycobacteriaceae | 3 | 2023 | 21 | 0.570 |
Why?
| | Neuroimmunomodulation | 6 | 2019 | 70 | 0.570 |
Why?
| | Memory Disorders | 5 | 2016 | 154 | 0.570 |
Why?
| | Antigens, CD | 2 | 2017 | 441 | 0.550 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 193 | 0.510 |
Why?
| | Male | 47 | 2023 | 55731 | 0.510 |
Why?
| | Central Nervous System | 2 | 2018 | 238 | 0.510 |
Why?
| | Down-Regulation | 1 | 2017 | 599 | 0.500 |
Why?
| | Methamphetamine | 1 | 2015 | 51 | 0.490 |
Why?
| | Carrier Proteins | 3 | 2015 | 696 | 0.490 |
Why?
| | Corticosterone | 7 | 2019 | 211 | 0.480 |
Why?
| | Peripheral Nervous System Diseases | 3 | 2010 | 120 | 0.450 |
Why?
| | Memory | 4 | 2018 | 209 | 0.430 |
Why?
| | Receptors, Interleukin-1 | 2 | 2012 | 227 | 0.410 |
Why?
| | Rats, Inbred F344 | 9 | 2018 | 241 | 0.390 |
Why?
| | Neuroglia | 3 | 2011 | 150 | 0.370 |
Why?
| | Mifepristone | 4 | 2019 | 60 | 0.330 |
Why?
| | Disease Susceptibility | 1 | 2011 | 316 | 0.320 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 145 | 0.320 |
Why?
| | RNA, Messenger | 6 | 2020 | 2563 | 0.320 |
Why?
| | Endotoxins | 1 | 2009 | 205 | 0.310 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 928 | 0.310 |
Why?
| | RNA, Antisense | 1 | 2007 | 17 | 0.290 |
Why?
| | Spinal Cord | 7 | 2023 | 348 | 0.280 |
Why?
| | Oxidative Stress | 1 | 2013 | 1085 | 0.280 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2007 | 83 | 0.280 |
Why?
| | Genes, MHC Class II | 1 | 2006 | 70 | 0.260 |
Why?
| | Signal Transduction | 2 | 2023 | 4525 | 0.260 |
Why?
| | Nerve Tissue Proteins | 1 | 2009 | 529 | 0.260 |
Why?
| | Neuralgia | 2 | 2023 | 122 | 0.260 |
Why?
| | Centrifugation | 1 | 2005 | 31 | 0.260 |
Why?
| | Histocompatibility Antigens | 1 | 2006 | 100 | 0.250 |
Why?
| | Immunity, Innate | 4 | 2015 | 723 | 0.240 |
Why?
| | Cell Separation | 1 | 2005 | 291 | 0.230 |
Why?
| | Interleukins | 1 | 2006 | 236 | 0.230 |
Why?
| | Receptors, Glucocorticoid | 3 | 2016 | 131 | 0.230 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 344 | 0.210 |
Why?
| | Substance-Related Disorders | 1 | 2011 | 946 | 0.210 |
Why?
| | Interleukin-6 | 5 | 2023 | 676 | 0.200 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 6 | 0.200 |
Why?
| | Extinction, Psychological | 1 | 2022 | 78 | 0.200 |
Why?
| | Hot Temperature | 2 | 2022 | 304 | 0.200 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 182 | 0.190 |
Why?
| | Vaccination | 2 | 2020 | 1205 | 0.180 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 93 | 0.180 |
Why?
| | Phosphate-Binding Proteins | 1 | 2020 | 5 | 0.180 |
Why?
| | Toll-Like Receptor 2 | 2 | 2013 | 109 | 0.180 |
Why?
| | Immunization | 3 | 2018 | 400 | 0.180 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 797 | 0.180 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 10 | 0.170 |
Why?
| | Interleukin-10 | 4 | 2014 | 297 | 0.170 |
Why?
| | Chronic Pain | 1 | 2023 | 210 | 0.170 |
Why?
| | Caspase 1 | 1 | 2020 | 140 | 0.170 |
Why?
| | Killer Cells, Natural | 1 | 2002 | 383 | 0.170 |
Why?
| | HEK293 Cells | 1 | 2021 | 590 | 0.170 |
Why?
| | Depressive Disorder | 1 | 2002 | 333 | 0.170 |
Why?
| | Hyperalgesia | 3 | 2011 | 107 | 0.170 |
Why?
| | Circadian Rhythm | 3 | 2018 | 354 | 0.160 |
Why?
| | Interleukin-4 | 1 | 2020 | 209 | 0.160 |
Why?
| | Macrophages | 4 | 2023 | 1267 | 0.160 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 286 | 0.160 |
Why?
| | Rats, Inbred BN | 4 | 2012 | 52 | 0.160 |
Why?
| | Cognition | 2 | 2018 | 983 | 0.160 |
Why?
| | Receptors, Pattern Recognition | 1 | 2018 | 9 | 0.150 |
Why?
| | Fear | 4 | 2022 | 292 | 0.150 |
Why?
| | Bacterial Vaccines | 1 | 2018 | 61 | 0.150 |
Why?
| | Genetic Therapy | 3 | 2010 | 258 | 0.150 |
Why?
| | Blood Proteins | 1 | 2020 | 233 | 0.150 |
Why?
| | Plasmids | 2 | 2010 | 345 | 0.140 |
Why?
| | Up-Regulation | 2 | 2013 | 812 | 0.140 |
Why?
| | Frontal Lobe | 1 | 2018 | 140 | 0.140 |
Why?
| | Humans | 14 | 2023 | 115042 | 0.140 |
Why?
| | Time Factors | 6 | 2016 | 6141 | 0.140 |
Why?
| | Lipid Metabolism | 1 | 2020 | 449 | 0.140 |
Why?
| | Affect | 1 | 2018 | 246 | 0.130 |
Why?
| | Amygdala | 1 | 2017 | 170 | 0.130 |
Why?
| | Neurogenic Inflammation | 1 | 2016 | 2 | 0.130 |
Why?
| | Drug Synergism | 2 | 2013 | 317 | 0.130 |
Why?
| | Adrenalectomy | 2 | 2014 | 60 | 0.130 |
Why?
| | Anxiety | 2 | 2020 | 845 | 0.130 |
Why?
| | Diet, High-Fat | 1 | 2016 | 225 | 0.120 |
Why?
| | Illness Behavior | 1 | 2014 | 10 | 0.120 |
Why?
| | Ventral Tegmental Area | 1 | 2015 | 45 | 0.120 |
Why?
| | Spleen | 2 | 2014 | 486 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2013 | 315 | 0.120 |
Why?
| | Prefrontal Cortex | 2 | 2015 | 261 | 0.120 |
Why?
| | Brain Mapping | 1 | 2018 | 523 | 0.120 |
Why?
| | Behavior, Animal | 3 | 2012 | 462 | 0.120 |
Why?
| | Circadian Clocks | 1 | 2014 | 42 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2015 | 125 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 273 | 0.120 |
Why?
| | Liver | 2 | 2014 | 1681 | 0.120 |
Why?
| | Laparotomy | 2 | 2011 | 97 | 0.110 |
Why?
| | Proteomics | 1 | 2020 | 844 | 0.110 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 124 | 0.110 |
Why?
| | CD11b Antigen | 2 | 2010 | 58 | 0.110 |
Why?
| | Sex Characteristics | 1 | 2018 | 635 | 0.110 |
Why?
| | Physical Conditioning, Animal | 2 | 2014 | 196 | 0.110 |
Why?
| | Injections, Spinal | 6 | 2010 | 101 | 0.110 |
Why?
| | Injections | 2 | 2013 | 159 | 0.110 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 926 | 0.100 |
Why?
| | Pain | 4 | 2011 | 709 | 0.100 |
Why?
| | DNA | 2 | 2010 | 1352 | 0.100 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2011 | 39 | 0.100 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 37 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 1857 | 0.090 |
Why?
| | Interleukin-1 | 2 | 2007 | 970 | 0.090 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2010 | 56 | 0.090 |
Why?
| | Raphe Nuclei | 1 | 2011 | 110 | 0.090 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2012 | 164 | 0.090 |
Why?
| | Immune System | 1 | 2012 | 172 | 0.090 |
Why?
| | Transcription Factors | 1 | 2018 | 1531 | 0.090 |
Why?
| | Fever | 1 | 2011 | 280 | 0.090 |
Why?
| | Genes, fos | 1 | 2009 | 33 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2010 | 2329 | 0.080 |
Why?
| | Microfilament Proteins | 1 | 2010 | 126 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2010 | 147 | 0.080 |
Why?
| | Hyperesthesia | 2 | 2006 | 7 | 0.080 |
Why?
| | Calcium-Binding Proteins | 1 | 2010 | 205 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 353 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2012 | 475 | 0.080 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2009 | 125 | 0.080 |
Why?
| | Neuronal Plasticity | 1 | 2009 | 209 | 0.070 |
Why?
| | Hydrocortisone | 1 | 2009 | 267 | 0.070 |
Why?
| | Foreign-Body Reaction | 1 | 2007 | 22 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1138 | 0.070 |
Why?
| | Pain Threshold | 1 | 2007 | 67 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2013 | 3545 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2018 | 3896 | 0.070 |
Why?
| | Catheterization | 1 | 2007 | 159 | 0.070 |
Why?
| | Immunohistochemistry | 2 | 2010 | 1634 | 0.070 |
Why?
| | DNA, Complementary | 1 | 2006 | 257 | 0.060 |
Why?
| | Minocycline | 1 | 2005 | 26 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 514 | 0.060 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.060 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 10 | 0.060 |
Why?
| | Constriction | 1 | 2023 | 45 | 0.060 |
Why?
| | Morphine | 1 | 2004 | 122 | 0.060 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 206 | 0.050 |
Why?
| | Electroshock | 2 | 2013 | 134 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2012 | 2150 | 0.050 |
Why?
| | Tissue Distribution | 2 | 2016 | 286 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2006 | 799 | 0.050 |
Why?
| | Age of Onset | 1 | 2002 | 449 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2002 | 484 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1523 | 0.040 |
Why?
| | Escherichia coli | 2 | 2016 | 719 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2002 | 1084 | 0.040 |
Why?
| | Pain Measurement | 2 | 2011 | 448 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2004 | 1019 | 0.040 |
Why?
| | Optical Fibers | 1 | 2018 | 17 | 0.040 |
Why?
| | Neurons | 1 | 2006 | 1284 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2018 | 68 | 0.040 |
Why?
| | Immunoassay | 1 | 2018 | 95 | 0.040 |
Why?
| | Host-Pathogen Interactions | 2 | 2011 | 295 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2004 | 774 | 0.040 |
Why?
| | Lipids | 1 | 2020 | 586 | 0.030 |
Why?
| | Memory, Long-Term | 1 | 2016 | 11 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2023 | 1318 | 0.030 |
Why?
| | Hormone Antagonists | 1 | 2016 | 33 | 0.030 |
Why?
| | Antibodies | 1 | 2018 | 372 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 336 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2016 | 369 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 5 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2020 | 436 | 0.030 |
Why?
| | Phenotype | 1 | 2002 | 2815 | 0.030 |
Why?
| | Proteins | 1 | 2020 | 915 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 292 | 0.030 |
Why?
| | Conditioning, Classical | 1 | 2014 | 87 | 0.030 |
Why?
| | Injections, Intraventricular | 1 | 2012 | 71 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2645 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 133 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 2715 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2011 | 91 | 0.020 |
Why?
| | Female | 3 | 2023 | 59613 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2011 | 78 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2010 | 79 | 0.020 |
Why?
| | Polyglycolic Acid | 1 | 2010 | 43 | 0.020 |
Why?
| | Serotonin | 1 | 2011 | 296 | 0.020 |
Why?
| | Particle Size | 1 | 2010 | 317 | 0.020 |
Why?
| | Amnesia, Anterograde | 1 | 2008 | 3 | 0.020 |
Why?
| | Exercise Test | 1 | 2011 | 545 | 0.020 |
Why?
| | Action Potentials | 1 | 2011 | 406 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 278 | 0.020 |
Why?
| | Parietal Lobe | 1 | 2008 | 41 | 0.020 |
Why?
| | Mice | 1 | 2023 | 14927 | 0.020 |
Why?
| | Hypothalamus | 1 | 2008 | 147 | 0.020 |
Why?
| | Cyclooxygenase 1 | 1 | 2007 | 20 | 0.020 |
Why?
| | Microinjections | 1 | 2006 | 77 | 0.020 |
Why?
| | Ligation | 1 | 2006 | 76 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 676 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2006 | 56 | 0.020 |
Why?
| | Nanoparticles | 1 | 2010 | 313 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 164 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2007 | 447 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2010 | 827 | 0.020 |
Why?
| | Receptors, HIV | 1 | 2004 | 23 | 0.020 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 18 | 0.020 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 21 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 33 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 719 | 0.010 |
Why?
| | Neuroprotective Agents | 1 | 2005 | 105 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 79 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 158 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1229 | 0.010 |
Why?
| | Middle Aged | 1 | 2002 | 26827 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 289 | 0.010 |
Why?
| | Adult | 1 | 2002 | 30656 | 0.010 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|